A Publication for the Practising Medical Specialist, Industry Executive

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. 

Stay Ahead in Medical Technology

At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.

In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.

Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.

Stay informed, stay connected, and join us as we navigate the future of healthcare together.

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Terumo Neuro Celebrates 15 Years of the WEB Device: A Game-Changing Innovation in Aneurysm Treatment

Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: “The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care.”

Paragonix Technologies Secures Official EU MDR Approval for 5 Organ Preservation Devices

Dr. Lisa Anderson, President of Paragonix Technologies. “This achievement validates our technology’s safety and effectiveness while expanding our ability to serve patients and healthcare providers in critical transplant care across the world. With this approval and the support structure provided by Sweden-based Getinge, we are dedicated to setting new standards in organ preservation, advancing the future of transplantation, and making a global impact.”

Clinical Trials

PharmaEssentia Completes Patient Enrollment for Phase 2b EXCEED-ET Trial in Essential Thrombocythemia and Phase 3b ECLIPSE-PV Trial in Polycythemia Vera

“Myeloproliferative neoplasms, including ET and PV, are chronic blood diseases that can impact patients’ quality of life and lead to life-threatening complications, including the development of specific types of blood cancers, and PharmaEssentia is committed to developing new therapeutic solutions for these patients,” said Robert B. Geller, M.D., Head of Medical at PharmaEssentia USA. “We are thrilled with the pace at which we have enrolled patients, which we believe reflects a high level of interest in both the EXCEED-ET and ECLIPSE-PV trials. Our goal with each of these programs is to redefine the early treatment paradigm of myeloproliferative neoplasms.”

Micro Medical Solutions | Achieves Milestone with 200th Enrollment in HEAL Registry

reg Sullivan, CEO of Micro Medical Solutions. “This milestone is a testament to our commitment to providing innovative solutions for those suffering from CLI/CLTI. We are optimistic about the encouraging data that has emerged from the registry and look forward to utilizing this information to continue providing effective treatment options.”

Biotechnology News

AliveDx Receives IVDR-CE Mark for Multiplexed Assay to Accurately Detect Celiac Disease on the MosaiQ® System

“We are thrilled to obtain the CE mark for our MosaiQ AiPlex CD microarray,” said Manuel O. Mendez, CEO of AliveDx. “The MosaiQ fast portfolio expansion marks our fourth microarray CE mark approval in the last 12 months reflecting our dedication to rapidly advance diagnostic technologies and our commitment to support the millions of individuals affected by autoimmune diseases. Early and accurate diagnosis is crucial for managing this condition. Our innovative MosaiQ microarray solutions represent a significant advancement to partner with laboratorians and clinicians to reduce healthcare costs and improve patient outcomes and quality of life.” 

PHC

PHC Unveils Prototype of LiCellGrow, New Cell Expansion System to Support Development of Cell and Gene Therapy Products Manufacturing Process

PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, hereinafter referred to as “Biomedical Division”) will showcase a prototype of its new cell expansion system LiCellGrow at the ISCT (International Society for Cell & Gene Therapy) Europe 2024 Regional Meeting held in Gothenburg, Sweden on September 4-6.

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

Home Delivery

Increases in Home Delivery and the Growth of Major Shippers Highlight 2024 Trends | By Tim McClatchy, Head of Life Sciences, Kenco

The growth of in-home care along with technology improvements like AI are shifting how medical device companies manage their inventory and final-mile deliveries. This, coupled by the increase of innovations like robotic-assisted surgeries, is creating a lasting impact on the medical devices supply chain. In fact, the healthcare third-party logistics (3PL) market is expected to grow at a compound annual growth rate of 7.6% from 2023 to 2030.

Executives on the Move

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Kazia Therapeutics Announces $2 Million Registered Direct Offering

Kazia has also agreed to issue in a concurrent private placement unregistered warrants to purchase up to an aggregate of 4,444,445 ADSs. The warrants will have an exercise price of $0.583 per ADS, will be immediately exercisable upon issuance, and will expire five and one-half years from the date of issuance. The closing of the offering is expected to occur on or about December 5, 2023, subject to the satisfaction of customary closing conditions.

Market Reports

Advancements In Imaging

CT System

AI-powered CT System Launches Reports Philips

Philips CT 3500, is a new high-throughput CT system targeting the needs of routine radiology and high-volume screening programs. Powered by AI, the Philips CT 3500 includes a range of image-reconstruction and workflow-enhancing features that help to deliver the consistency, speed, and first-time-right image quality needed for confident diagnoses by clinicians and increased return on investment – even in the most demanding, high-volume care settings. 

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

9 Tips For Critical Care Nurses

9 Tips For Critical Care Nurses

Nurses today are worried about being overworked, understaffed, and seriously exhausted. Among many nursing vocations, critical care nurses have more duties than traditional RNs. Experts

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.